30 results about "IV Infusion" patented technology

An IV device assembly may include a lumen forming a fluidic channel within the IV device assembly. The lumen may be fluidically coupled to a vascular access device (VAD) coupler via a funnel coupler, and an IV device assembly coupler at a proximal end of the lumen. The IV device assembly may also include one or more of the following: a collapsible sleeve formed coaxially around a first portion of the lumen and mechanically coupled to the funnel coupler, a probe formed along a second portion of the lumen within the collapsible sleeve and into the VAD coupler, a translation handle that translates the probe out of a distal end of the VAD coupler, and a fixed grip formed around the lumen to maintain a position of the IV device assembly relative to the translation handle.

A closed, gravity-fed burette for intravenous (IV) fluid delivery and flush system supporting multiple input combinations for simplicity and standardization. Able to handle both hazardous and non-hazardous drugs, this system may incorporate plastic and elastomeric materials that are resistant to the effects of antineoplastic materials in conjunction with a hazardous air filter module while still integration compatible with electronic peristaltic pumps for finer control of flow rate and when the IV infusion recipient's physical position is not compatible with a gravity-fed flow. The buoyant-activated shuttle valve enables the AutoStart function providing steady flush of the IV line to the patient for optimized vein patency from the Primary IV fluid feed. This Primary line works in conjunction with a Secondary IV fluid feed and a needleless connector Drug Port for multiple feed and flush conditions directed by way of a monoblock design supporting combinations of rotary, toggle, and check valves.

Disinfection cap includes housing comprising closed top, essentially cylindrical sidewall, and open bottom formed by the sidewall with opening to inner cavity within the housing for receiving tip including mating feature of needleless connector. Disinfection sponge can be configured within inner cavity, removable cover sealing opening to inner cavity to seal sponge within inner cavity prior to cap use. Inner cavity includes at least one thread on inner surface of its sidewall that does not correspond to the mating feature of needleless connector, but is sufficient to interlock with mating feature of needleless connector. Plurality of disinfection caps are disposed on strip of IV pole hanging device such that each cap can be peeled off the strip unsealed for immediate use, or separated from the strip sealed for later use.

AI ENABLED IV INFUSION MONITORING DEVICE FOR REAL-TIME NURSING CARE OPTIMISATION

To provide a one-time priming IV extension set configured simply to connect a syringe having priming infusion to one of a plurality of tube branches.SOLUTION: A multi-tube intravenous IV extension set may include: an outlet tube fluidly coupled to a primary multi-tube connector at one end and fluidly coupled to a vascular device at an opposite end; and a primary inlet tube having a proximal end with an adapter for connection to a syringe containing a priming or a medicinal fluid, and a distal end coupled to the primary multi-tube connector. The IV extension set may further include at least one secondary inlet tube with a proximal end having an adapter for receiving a medicinal fluid and a distal end selectively fluidly coupled to the primary multi-tube connector.SELECTED DRAWING: Figure 2A

This is a non-kink IV device for placement on an arm of a patient called a Silent antecubital (AC). The non-kink IV device includes a small amount of a compressed material with a rounded bottom, at least one elastic band, and a stretchy net piece to encase the roll and bands around the arm of the patient. The device holds the IV against the arm so that arm movement of the patient is limited to avoid kinking of any tubing for the IV since the kinking can set off an alarm. Options for the compressed material are a compressed roll of gauze, an inflatable bladder, a soft rubber ball which can be a soft rubber made of a fully FDA compliant material such as rubber, silicone, various plastics, a composite material, and a fiber cloth.

A device for the uninterrupted administration of fluid to an animal body during a draw of bodily fluid, e.g., blood from a blood vessel, is disclosed. A first fluid channel is configured to selectively transport IV fluid to an animal body and to draw a bodily fluid from the blood vessel via a catheter. A sealing member for sealing a blood draw port defines a concave surface on a first end. An outlet connector is configured to connect to a catheter to the first fluid channel and defines a concave distal end. An IV fluid inlet fluidly connected to an IV infusion lumen and configured for fluidic connection to an IV fluid source and uninterrupted delivery of IV fluid to the blood vessel. A valve member selectively provides a fluidic connection between the outlet connector and the IV fluid inlet, thereby selectively alternating between blood collection and IV fluid delivery.

A flushing device for use with an IV infusion appliance and an IV infusion appliance with an automatic flushing function. The IV appliance comprises a rigid and / or non-collapsible irrigation fluid chamber (3) which is directly connected to a fluid flow path for the IV fluid at an irrigation height (FH) through an irrigation opening (7) and at a ventilation height (VH) through a ventilation opening (17). The vent (17) allows air from the fluid flow path into the irrigation fluid chamber (2) when the level of IV liquid in the fluid flow path falls below a vent height (VH) and irrigation fluid from the irrigation fluid chamber (2) into the fluid flow path via the irrigation port (7) when the level of IV liquid falls below the vent height (VH) during use of the IV infusion appliance, this allows the flushing fluid chamber (2) to be discharged into the fluid flow path at least partially due to gravity.

Systems, devices and methods are described for mounting medical equipment on IV poles, bed rails and other supporting structures in medical facilities including operating rooms and critical care sections. A system including a mounting hanger and corresponding equipment housing is disclosed that allows quick mounting and dismounting of equipment from a supporting structure. The novel structural design of mounting hanger including a symmetrical t-slot feature and a plunger lock allows a piece of equipment to be mounted on a supporting structure in multiple orientations as per the requirement which allows a user to optimize the placement of equipment in the medical environment.

A closed, gravity-fed measured volume burette for intravenous (IV) fluid delivery and flush system supporting multiple input combinations for simplicity and standardization. Able to handle both hazardous and non-hazardous drugs, this system may incorporate plastic and elastomeric materials that are resistant to the effects of antineoplastic materials in conjunction with a hazardous air filter module while still integration compatible with electronic peristaltic pumps for finer control of flow rate and when the IV infusion recipient's physical position is not compatible with a gravity-fed flow. The buoyant-activated shuttle valve enables the AutoStart function providing steady flush of the IV line to the patient for optimized vein patency from the Primary IV fluid feed. This Primary line works in conjunction with a Secondary IV fluid feed and a needleless connector Drug Port for multiple feed and flush conditions directed by way of a monoblock design supporting combinations of rotary, toggle, and check valves.

There is provided an IV flow regulator, which includes an upper lever; a lower lever which is disposed below the upper lever and regulates the flow rate of the IV by a regulation operation of rotating by facing the upper lever; a cover fastened to the lower lever; and switching restraint unit which switches a restraint state in which the cover and the lower lever are mutually restrained to enable the regulation operation and a free state in which the cover and the lower lever are not mutually restrained to disable the regulation operation, according to a relative position of the cover and the lower lever.

An IV device assembly may include a lumen that forms a fluidic channel within the IV device assembly. The lumen may be fluidly coupled to a vascular access device (VAD) coupler by a funnel coupler, and an IV device assembly coupler at a proximal end of the lumen. The IV device assembly may also include one or more of the following: a foldable cuff formed coaxially around a first portion of the lumen and mechanically coupled to the funnel coupler, a probe formed along a second portion of the lumen within the foldable cuff and in the VAD coupler, a translation handle that translates the probe from a distal end of the VAD coupler, and a fixed loop formed around the lumen to maintain a position of the IV device assembly relative to the translation handle.

A flushing apparatus for use with an IV infusion set and an IV infusion set having an automatic flushing function. The IV set comprises a rigid and / or non-collapsible flushing liquid chamber (2), that is connected to a fluid flow path for IV fluid from a source of IV fluid to a patient via a flushing port at a flushing height (FH) and via a venting port at a venting height (VH). The venting port comprises an outlet opening (19) that connects to the flushing liquid chamber (2) and an inlet opening (17) that connects to an IV fluid flow path. The outlet opening (19) is arranged higher than the inlet opening (17) and higher than the initial level of the flushing liquid in the flushing liquid chamber (2). The flushing height (FH) is lower than the venting height (VH). When the level of IV liquid in the fluid flow path falls below the venting height (VH) the venting port allows air from the fluid flow path to enter the flushing liquid chamber (2) and flushing liquid from the flushing liquid chamber (2) to enter the fluid flow path via the flushing port when, during use of the IV infusion set the IV liquid level falls below the venting height (VH), thereby allowing the flushing liquid chamber (2) to be drained at least partially by gravity into the fluid flow path.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5° C., even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5 °C, even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

An asset tracking system includes first and sensing units and a computing device. The first sensing unit senses when a product is stored and unused, while the second sensing unit senses when the product is used. The computing device changes a maintenance counter at different rates depending upon the usage or storage of the product. When the maintenance counter reaches a target, the computing device notifies appropriate personnel of a maintenance event, such as replacement or repair. A patient support apparatus may include the second sensing unit. Alternatively, or additionally, the patient support apparatus may automatically determine when a mattress thereon has been lifted for proper cleaning of the surface underneath the mattress. The patient support apparatus may also, or alternatively, automatically determine when access is gained to an enclosure on the patient support apparatus or on another product, and / or automatically determine when an IV pole is bent.

To provide an improved IV drip rate measurement system and associated drip chamber for use in an IV fluid administration system.SOLUTION: The present disclosure relates to a system for measuring drip rate including a drip chamber device including an elongated body having an inner surface defining a chamber, and a drip rate measurement device. The drip chamber may be fluidly coupled to a container containing IV fluid configured to drip droplets of the IV fluid into the chamber, and the drip rate measurement device may include a housing and a load cell transducer. The load cell transducer may be configured to measure the weight of a droplet of IV fluid and convert the weight into an electrical signal. The drip rate measurement device may include a controller electrically coupled to the load cell transducer to process the electrical signal and output at least one parameter associated with the IV fluid.SELECTED DRAWING: Figure 2B

Infusion connection lines are provided for use with infusion sets. The infusion connection line includes a pump infusion tubing with connectors at both ends and an indicator element to show the installation direction within an infusion pump, which is placed between the connectors. The infusion connection line is configured to connect a gravity IV set to any type of infusion pump while improving pump infusion accuracy and minimizing leakage or tubing breakage by directly over-connecting the gravity IV set to the infusion pump. The infusion connection line can be disconnected and disposed of after use without requiring the removal of the rest of the pump IV infusion set and / or components.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5° C., even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5° C., even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

A closed, gravity-fed measured volume burette for intravenous (IV) fluid delivery and flush system supporting multiple input combinations for simplicity and standardization. Able to handle both hazardous and non-hazardous drugs, this system may incorporate plastic and elastomeric materials that are resistant to the effects of antineoplastic materials in conjunction with a hazardous air filter module while still integration compatible with electronic peristaltic pumps for finer control of flow rate and when the IV infusion recipient's physical position is not compatible with a gravity-fed flow. The buoyant-activated shuttle valve enables the AutoStart function providing steady flush of the IV line to the patient for optimized vein patency from the Primary IV fluid feed. This Primary line works in conjunction with a Secondary IV fluid feed and a needleless connector Drug Port for multiple feed and flush conditions directed by way of a monoblock design supporting combinations of rotary, toggle, and check valves.

A peripheral intravenous (IV) catheter assembly having blood sampling and cannulation capabilities can have a blood collection holder (106) that has a needle hub (106a) attached to a catheter hub (102). The combination of the catheter assembly and the blood sampling holder can be referred to as a catheter and holder assembly (85). After cannulation, blood sampling can be performed directly through the needle and the blood collection holder. After blood sampling, the blood collection holder (106) and the needle (108) can be removed, leaving the catheter hub (102) with the patient for IV infusion. The catheter hub (102) can be a straight catheter hub or can include a side fluid port (500) for use as an integral IVC.

A cord sling device is described and comprises an organizer used to hold a multitude of cords on medical devices such as IV poles. The cord sling device comprises a body component with adjustable fasteners designed to hang up the device and tie up cords and cables. Thus, once the device is hung from an IV pole or other equipment, and the wrapped cords are hung from the adjustable cord fasteners, a user can ensure a safer, more organized, and visually appealing environment for cords and cables. Further, the cord sling device protects cords and cables from wear and tear, or from becoming separated and unprotected thereby shortening the life span of the cords and cables. Also, the cord sling device enables for better airflow and prevents possible overheating issues with electronic devices.

This item is an endoscope auxiliary tool that holds an endoscope and assists in its operation. The names of each part are listed in the "Reference Oblique View Showing the Names of Each Part." The first and second levers are attached so that they can slide relative to each other. The shaft fixing part is fixed to the second lever, and is fixed to a shaft that extends vertically, such as an IV stand. An endoscope can be inserted and fixed into three endoscope fixing parts: one on the first lever and two on the second lever. The six-sided view and perspective view are drawn with the first lever stored within the second lever. The perspective view of the first lever when unfolded, i.e., when the first and second levers are extended, is shown in the "Reference Oblique View Showing the Extended State."

Degassing or flushing an IVL catheter balloon. The method includes providing inflation fluid to a catheter balloon from a first fluid reservoir having a positive pressure to inflate the catheter balloon. The method further includes removing at least a portion of the inflation fluid from the catheter balloon to a second fluid reservoir, different from the first fluid reservoir having a negative pressure.

Invention disclosed herein provides a method for the treatment of DLL3-positive cancer or SCLC, comprising administering to a subject in need thereof an anti-DLL3 agent alone, or in combination with an anti-PD-L 1 antibody and / or chemotherapeutic agents. Step dosing or extended IV infusion of the anti-DLL3 agent is also disclosed.

The IV infusion set includes at least one infusion component, a first IV tubing coupled to the infusion component, a second IV tubing, and a disposable pump head. The pump head includes an inlet port coupled to the first IV tubing, an outlet port coupled to the second IV tubing, and a drive interface configured to be coupled to a first end of a drive shaft. The drive interface is configured to be rotated by rotation of the drive shaft, which has a second end coupled to a driver to increase fluid flow rate through the IV infusion set. An IV set assembly and methods of use are also provided.

A drug delivery system includes a delivery container, a first drug insertion port, at least one additional drug insertion port, and an IV connection port. The delivery container includes upper, lower, first side, and second side portions, and further includes a tapered region extending between the first side portion and the second side portion. The first drug insertion port is positioned at the lower portion of the delivery container and has a first coupling mechanism. The at least one additional drug insertion port is also positioned at the lower portion of the delivery container, but includes a second coupling mechanism that is different than the first coupling mechanism. The IV connection port is positioned at the lower portion of the delivery container adjacent to a lower portion of the tapered region.

To provide an IV catheter assembly with one-handed operation for work, in particular, having an IV catheter related to a needle device and an IV (intravenous) injection device.SOLUTION: An extension retention catheter assembly includes a housing having an inner side in which a catheter assembly that can include a catheter tube and a needle is arranged. The catheter tube of the catheter assembly can be arranged intravenously of a patient even with and without a guide wire. Then, the extension retention catheter assembly can be operated such as to be divided into two or more housing components, or by opening a gate which allows the division of the catheter assembly from the housing. A needle guard can be included to cover a tip end part of the needle to prevent any unwanted needle pricking.SELECTED DRAWING: Figure 1